137 related articles for article (PubMed ID: 34200155)
1. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain.
Bonnin P; Vitalis T; Schwendimann L; Boutigny A; Mohamedi N; Besson VC; Charriaut-Marlangue C
Curr Issues Mol Biol; 2021 Jun; 43(1):301-312. PubMed ID: 34200155
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke.
Charriaut-Marlangue C; Leconte C; Csaba Z; Chafa L; Pansiot J; Talatizi M; Simon K; Moretti R; Marchand-Leroux C; Baud O; Besson VC
Brain Behav Immun; 2018 Oct; 73():375-389. PubMed ID: 29852289
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway.
Bonnin P; Charriaut-Marlangue C; Pansiot J; Boutigny A; Launay JM; Besson VC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911782
[TBL] [Abstract][Full Text] [Related]
4. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
[TBL] [Abstract][Full Text] [Related]
5. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
6. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain.
Moretti R; Leger PL; Besson VC; Csaba Z; Pansiot J; Di Criscio L; Gentili A; Titomanlio L; Bonnin P; Baud O; Charriaut-Marlangue C
J Neuroinflammation; 2016 Apr; 13(1):95. PubMed ID: 27126393
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
[TBL] [Abstract][Full Text] [Related]
9. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
10. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
12. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
13. Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
Lechaftois M; Dreano E; Palmier B; Margaill I; Marchand-Leroux C; Bachelot-Loza C; Lerouet D
PLoS One; 2014; 9(10):e110776. PubMed ID: 25329809
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
[TBL] [Abstract][Full Text] [Related]
15. Intervention timing and effect of PJ34 on astrocytes during oxygen-glucose deprivation/reperfusion and cell death pathways.
Cai C; Zhang R; Huang QY; Cao X; Zou LY; Chu XF
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):397-404. PubMed ID: 26072080
[TBL] [Abstract][Full Text] [Related]
16. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
[TBL] [Abstract][Full Text] [Related]
18. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
[TBL] [Abstract][Full Text] [Related]
19. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
[TBL] [Abstract][Full Text] [Related]
20. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.
Hamby AM; Suh SW; Kauppinen TM; Swanson RA
Stroke; 2007 Feb; 38(2 Suppl):632-6. PubMed ID: 17261705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]